Potent clinical predictive and systemic adjuvant therapeutic value of plasma fractalkine in PD-L1/PD-1 blockade immunotherapy for lung cancer
Ana Bocanegra, Gonzalo Fernández, Daniel Ajona, Hugo Arasanz, Ester Blanco, Miren Zuazo, Luisa Chocarro, Sergio Piñeiro-Hermida, Pilar Morente, Leticia Fernández, Maider Garnica, Ana Remirez, Maite Martinez-Aguillo, Idoia Morilla, Beatriz Tavira, Pablo Ramos, Miriam Echaide, Juan José Lasarte, Luis Montuenga, Ruth Vera, Ruben Pio, David Escors, Grazyna Kochan
doi: https://doi.org/10.1101/2022.06.16.22276511
Ana Bocanegra
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
Gonzalo Fernández
2Medical Oncology Department, San Carlos Clinical Hospital, IdISSC, San Carlos Clinical Hospital Institute for Health Research, Madrid, Spain.
Daniel Ajona
4Program in Solid Tumors, CIMA-University of Navarre-IdISNA, Pamplona, Spain.
5CIBERONC, Centro de Investigación Biomédica en Red de Cáncer.
6Department of Biochemistry and Genetics, School of Sciences, University of Navarra-IdISNA, Pamplona, Spain.
Hugo Arasanz
3Department of Oncology, Hospital Universitario de Navarra-IdISNA, Pamplona, Navarra, Spain.
Ester Blanco
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
7Program in Gene Therapy and Regulation of Gene Expression, CIMA-University of Navarra-IdISNA, Pamplona, Spain.
Miren Zuazo
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
Luisa Chocarro
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
Sergio Piñeiro-Hermida
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
Pilar Morente
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
Leticia Fernández
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
Maider Garnica
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
Ana Remirez
4Program in Solid Tumors, CIMA-University of Navarre-IdISNA, Pamplona, Spain.
Maite Martinez-Aguillo
3Department of Oncology, Hospital Universitario de Navarra-IdISNA, Pamplona, Navarra, Spain.
Idoia Morilla
3Department of Oncology, Hospital Universitario de Navarra-IdISNA, Pamplona, Navarra, Spain.
Beatriz Tavira
4Program in Solid Tumors, CIMA-University of Navarre-IdISNA, Pamplona, Spain.
8Cancer Center University of Navarra (CCUN), Pamplona, Spain.
9Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra-IdISNA, Pamplona, Spain.
Pablo Ramos
2Medical Oncology Department, San Carlos Clinical Hospital, IdISSC, San Carlos Clinical Hospital Institute for Health Research, Madrid, Spain.
Miriam Echaide
2Medical Oncology Department, San Carlos Clinical Hospital, IdISSC, San Carlos Clinical Hospital Institute for Health Research, Madrid, Spain.
Juan José Lasarte
8Cancer Center University of Navarra (CCUN), Pamplona, Spain.
10Program in Immunology and Immunotherapy, CIMA-University of Navarra-IdISNA, Pamplona, Spain.
Luis Montuenga
4Program in Solid Tumors, CIMA-University of Navarre-IdISNA, Pamplona, Spain.
5CIBERONC, Centro de Investigación Biomédica en Red de Cáncer.
9Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra-IdISNA, Pamplona, Spain.
Ruth Vera
3Department of Oncology, Hospital Universitario de Navarra-IdISNA, Pamplona, Navarra, Spain.
Ruben Pio
4Program in Solid Tumors, CIMA-University of Navarre-IdISNA, Pamplona, Spain.
5CIBERONC, Centro de Investigación Biomédica en Red de Cáncer.
6Department of Biochemistry and Genetics, School of Sciences, University of Navarra-IdISNA, Pamplona, Spain.
David Escors
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
Grazyna Kochan
1Oncoimmunology group, Navarrabiomed-IdISNA, Pamplona, Navarra, Spain.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted June 21, 2022.
Potent clinical predictive and systemic adjuvant therapeutic value of plasma fractalkine in PD-L1/PD-1 blockade immunotherapy for lung cancer
Ana Bocanegra, Gonzalo Fernández, Daniel Ajona, Hugo Arasanz, Ester Blanco, Miren Zuazo, Luisa Chocarro, Sergio Piñeiro-Hermida, Pilar Morente, Leticia Fernández, Maider Garnica, Ana Remirez, Maite Martinez-Aguillo, Idoia Morilla, Beatriz Tavira, Pablo Ramos, Miriam Echaide, Juan José Lasarte, Luis Montuenga, Ruth Vera, Ruben Pio, David Escors, Grazyna Kochan
medRxiv 2022.06.16.22276511; doi: https://doi.org/10.1101/2022.06.16.22276511
Potent clinical predictive and systemic adjuvant therapeutic value of plasma fractalkine in PD-L1/PD-1 blockade immunotherapy for lung cancer
Ana Bocanegra, Gonzalo Fernández, Daniel Ajona, Hugo Arasanz, Ester Blanco, Miren Zuazo, Luisa Chocarro, Sergio Piñeiro-Hermida, Pilar Morente, Leticia Fernández, Maider Garnica, Ana Remirez, Maite Martinez-Aguillo, Idoia Morilla, Beatriz Tavira, Pablo Ramos, Miriam Echaide, Juan José Lasarte, Luis Montuenga, Ruth Vera, Ruben Pio, David Escors, Grazyna Kochan
medRxiv 2022.06.16.22276511; doi: https://doi.org/10.1101/2022.06.16.22276511
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (632)
- Anesthesia (168)
- Cardiovascular Medicine (2400)
- Dermatology (207)
- Emergency Medicine (381)
- Epidemiology (11797)
- Forensic Medicine (10)
- Gastroenterology (705)
- Genetic and Genomic Medicine (3769)
- Geriatric Medicine (350)
- Health Economics (637)
- Health Informatics (2408)
- Health Policy (940)
- Hematology (342)
- HIV/AIDS (787)
- Medical Education (369)
- Medical Ethics (105)
- Nephrology (401)
- Neurology (3524)
- Nursing (199)
- Nutrition (529)
- Oncology (1835)
- Ophthalmology (539)
- Orthopedics (221)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (66)
- Pathology (447)
- Pediatrics (1037)
- Primary Care Research (424)
- Public and Global Health (6184)
- Radiology and Imaging (1291)
- Respiratory Medicine (832)
- Rheumatology (380)
- Sports Medicine (324)
- Surgery (406)
- Toxicology (50)
- Transplantation (172)
- Urology (147)